Primary Analysis of the Phase II Component of a Phase I/II Dose Intensification Study Using Three-Dimensional Conformal Radiation Therapy and Concurrent Chemotherapy for Patients With Inoperable Non–Small-Cell Lung Cancer: RTOG 0117

PURPOSE: Phase I of Radiation Therapy Oncology Group (RTOG) 0117 determined that 74 Gy was the maximum-tolerated dose with concurrent weekly carboplatin/paclitaxel chemotherapy for inoperable non–small-cell lung cancer (NSCLC). Phase II results are reported here. PATIENTS AND METHODS: Patients with...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Bradley, Jeffrey D., Bae, Kyounghwa, Graham, Mary V., Byhardt, Roger, Govindan, Ramaswamy, Fowler, Jack, Purdy, James A., Michalski, Jeff M., Gore, Elizabeth, Choy, Hak
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Clinical Oncology 2010
Assuntos:
Original Reports
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2881726/
https://ncbi.nlm.nih.gov/pubmed/20368547
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2009.27.1205
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados